Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest (Q68447088)
Jump to navigation
Jump to search
scientific article published on 01 January 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest |
scientific article published on 01 January 1990 |
Statements
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study (English)
G E Goodman
J J Crowley
J C Blasko
R B Livingston
T M Beck
M D Demattia
1 January 1990